Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

Epithelial surface disruption in genital psoriatic lesions may manifest as erosions, fissures and/or ulcers, causing pain and significantly impacting a patient's sexual health.

[1]  M. Larsabal,et al.  GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis , 2018, The British journal of dermatology.

[2]  W. Liao,et al.  Treatment of Genital Psoriasis: A Systematic Review , 2018, Dermatology and Therapy.

[3]  A. Gottlieb,et al.  Efficacy and safety of ixekizumab in a randomized, double‐blinded, placebo‐controlled phase IIIb study of patients with moderate‐to‐severe genital psoriasis , 2018, The British journal of dermatology.

[4]  A. Gottlieb,et al.  The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS) , 2017, Dermatology and Therapy.

[5]  A. Gottlieb,et al.  The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health , 2017, Dermatology and Therapy.

[6]  E. Edson-Heredia,et al.  Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study , 2017, Dermatology and Therapy.

[7]  L. Coates,et al.  British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017 , 2017, The British journal of dermatology.

[8]  A. Gottlieb,et al.  The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis. , 2017, Journal of drugs in dermatology : JDD.

[9]  B. Strober,et al.  Clinical meaningfulness of complete skin clearance in psoriasis. , 2016, Journal of the American Academy of Dermatology.

[10]  P. Gisondi,et al.  European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  A. Menter,et al.  Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. , 2015, Journal of the American Academy of Dermatology.

[12]  L. Massuger,et al.  Genital psoriasis awareness program: physical and psychological care for patients with genital psoriasis. , 2015, Acta dermato-venereologica.

[13]  Antonio Guglielmetti,et al.  Inverse Psoriasis Involving Genital Skin Folds: Successful Therapy with Dapsone , 2012, Dermatology and Therapy.

[14]  R. Suárez-Fernández,et al.  [Vulvar inflammatory dermatoses]. , 2012, Actas dermo-sifiliograficas.

[15]  P. V. D. van de Kerkhof,et al.  Quality of life and sexual health in patients with genital psoriasis , 2011, The British journal of dermatology.

[16]  L. Massuger,et al.  Genital psoriasis: A systematic literature review on this hidden skin disease. , 2011, Acta dermato-venereologica.

[17]  P. V. D. van de Kerkhof,et al.  Genital psoriasis: a questionnaire‐based survey on a concealed skin disease in the Netherlands , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  R. Bissonnette,et al.  Efficacy and Tolerability of Topical Tacrolimus Ointment for the Treatment of Male Genital Psoriasis , 2008, Journal of cutaneous medicine and surgery.

[19]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.